Enables Bristol Myers Squibb to expand its manufacturing capacity, meeting the growing demand for its range of cell therapies through Cellares’ platform.
This webinar will cover the key steps and considerations involved in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages.
This white paper explores the various types of tech transfer from preclinical to commercial stages and proposes strategies to successfully foster innovation.
Kishore Hotha, VP Global Analytical R&D - Veranova
Agreement combines the capacity and capabilities of OBiO process development scientists with enabling platforms and support from Univercells Technologies.
The plant's automation is integrated from the plant floor through enterprise-level systems and combined with single-use equipment allowing rapid tech transfer.
AGC will assume technology transfer and feasibility study for drug product for the treatment of Idiopathic pulmonary fibrosis at its Cell & Gene CoE in Milan.
Offers analytical method validation and analytical services to support batch release, in additional to stability studies to enable rapid regulatory filing.
Achievements from the KTP partnership include the build and installation of flow rigs and successful delivery of multiple projects at 100’s of kgs scale.
As a company producing Oral Solid Dose drug products, how can Pharmaceutical Continuous Manufacturing solve specific problems and help your business thrive?